Speaker illustration

Mrs Belen Espinos

Barcelona (Spain)

Economic evaluation of rivaroxaban versus acenocoumarol in the prevention of stroke in patients with non-valvular atrial fibrillation in spain

Event: ESC Congress 2016

Topic: Stroke

Session: Stroke and more

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb